Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function

Ji‐Ru Cai, Jian Zhang, Yue‐Xin Ning, Wei Yang, Tian‐Ce Xu, Mei‐Chen Liu, Ke‐Xin Wang, Hui‐Sheng ChenAging 2026 · DOI

TL;DR

This study introduces periodic therapeutic phlebotomy (PTP) as a novel, simple, and safe method to combat aging. PTP effectively reverses age-related decline in cognitive function, organ health, and cellular senescence by rejuvenating the bone marrow's hematopoietic system, offering a promising avenue for clinical translation.

What Problem Does This Paper Address?

Aging is a major risk factor for numerous chronic diseases, driving a critical need for effective anti-aging strategies. While "young blood" interventions like heterochronic parabiosis have shown promise in reversing aging phenotypes, their clinical translation is hampered by limited plasma availability. This paper addresses the challenge of finding a more accessible and practical method to harness the rejuvenating power of blood exchange, specifically by investigating whether controlled blood removal (phlebotomy) can mimic these beneficial effects.

Methods

The researchers utilized a D-galactose-induced aging model in rats and mice to simulate accelerated aging. Periodic therapeutic phlebotomy (PTP) was administered either weekly (PTP/1w) or bi-weekly (PTP/2w). A battery of behavioral tests (Y-maze, Morris water maze, open field, treadmill, forced swim, tail suspension) assessed cognitive and motor function. Tissue and organ health were evaluated using histological staining (SA-β-gal, p-γH2A.X, Oil Red O, Sirius Red, HE, Masson's trichrome), immunohistochemistry, and RT-qPCR to measure senescence markers and structural integrity. Bone marrow function was analyzed through flow cytometry for hematopoietic stem and progenitor cells, and by assessing mesenchymal stem cell proliferation and senescence markers. Peripheral blood analysis included cytokine profiling and measurement of aging-related biomarkers. Electrophysiology was used to assess synaptic plasticity in the hippocampus.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Phlebotomy as a Rejuvenation Trigger: The study demonstrates that controlled blood withdrawal, rather than just infusion of young blood, can actively stimulate anti-aging mechanisms.
  • Bone Marrow as the Central Hub: PTP's primary mechanism appears to be the rejuvenation of the bone marrow microenvironment, restoring hematopoietic stem cell function and promoting a more youthful blood production profile.
  • Systemic Effects from Local Intervention: Improvements observed in cognitive function, organ health, and reduced systemic inflammation are directly linked to the restored bone marrow function, highlighting a powerful systemic effect from a localized intervention.
  • Dose-Dependent Efficacy: The bi-weekly PTP regimen (PTP/2w) generally showed more pronounced anti-aging effects than the weekly regimen (PTP/1w), suggesting an optimal frequency for balancing stimulation and recovery.

Key Results

  • Cognitive and Motor Improvements: PTP significantly improved working memory, spatial learning, and motor endurance in aged animals, with the PTP/2w group showing greater efficacy.
  • Reduced Senescence: PTP markedly decreased the expression of senescence markers (SA-β-gal, p-γH2A.X) and SASP components (IL-6, TNF-α) across multiple tissues (liver, kidney, hippocampus, heart, aorta, muscle, bone).
  • Organ Health Restoration: Histological analysis revealed mitigation of age-related structural degradation in the liver, kidney, muscle, bone, and skin.
  • Neurogenesis and Synaptic Plasticity: PTP promoted neurogenesis in the hippocampus and reversed age-related declines in synaptic plasticity, providing an electrophysiological basis for improved memory.
  • Peripheral Blood Rejuvenation: PTP increased anti-aging factors (Klotho, Taurine), normalized oxidative stress markers (MDA, SOD, GSH-PX), and restored T and B cell populations in the peripheral blood and immune organs.
  • Bone Marrow Rejuvenation: PTP reduced SA-β-gal positive cells in the bone marrow, normalized hematopoietic regulatory factors, and restored the balance of hematopoietic stem and progenitor cells, promoting lymphoid-biased proliferation.

Limitations and Future Work

The authors acknowledge several limitations:

  • Sex-Based Differences: The study primarily focused on male rats, with female rats not tested for certain outcomes. While mouse studies showed no sex-based differences, further investigation in female rats is warranted.
  • Aging Model: The use of a D-galactose-induced aging model, while convenient, does not fully replicate the complexity of natural aging. The authors are conducting studies in naturally aging mice to address this.
  • Mechanistic Links: While strong correlations were found, further experiments are needed to definitively establish the causal links between systemic blood changes and observed tissue improvements, particularly how blood functional restoration impacts downstream effects.
  • Functional Validation: The study's findings on BMSC and endothelial cell roles in rejuvenation are correlative. Future research should include functional assays like bone marrow transplantation to confirm these mechanisms.
  • Young Controls: The study did not evaluate PTP effects on young, healthy controls, hypothesizing minimal benefits due to their already optimal physiological state.
  • Iron Metabolism: The role of iron metabolism, a significant factor in aging and disease, was not explicitly investigated, highlighting the need to consider iron homeostasis in future PTP evaluations.

Future work should focus on clinical trials to translate these findings, optimize PTP protocols, and further elucidate the intricate mechanisms by which PTP promotes systemic rejuvenation.

Summary updated

Abstract

Aging is the primary risk factor for numerous chronic diseases, making the identification of safe and effective anti-aging strategies a critical focus in biomedical research. Heterochronic parabiosis by blood exchange shows that the exchange interaction between young and old plasma can exert anti-aging effects through exchange of bloodborne factors. However, the limited plasma source greatly affects clinical translation. Here, we demonstrate that periodic therapeutic phlebotomy in D-galactose-induced aging models exerts significant and comprehensive anti-aging effects, which is reflected by a notable improvement in aging-associated behavioral deficits and neurogenesis, a significant decrease in the level of circulating senescence-associated secretory phenotypes, and an obvious mitigation of aging-associated structural degradation and molecular alterations within the muscle, bone, liver, kidney, and nervous systems. Mechanistically, periodic therapeutic phlebotomy induces bone marrow microenvironment restoration through functional rescue of mesenchymal stem cells and endothelial cells, thereby reestablishing balanced hematopoietic homeostasis. This hematopoietic revitalization subsequently drives systemic improvements in peripheral blood composition and function. In conclusion, our work provides preliminary evidence suggesting that periodic therapeutic phlebotomy exerts anti-aging effects by restoring bone marrow function and mitigating aging phenotypes, subsequently driving peripheral blood functional restoration. Given its technical simplicity and safety profile, this periodic therapeutic phlebotomy strategy will hold potential to pave the way for clinical translation.
BibTeX
@inproceedings{cai2026periodic,
  author = {Ji‐Ru Cai and Jian Zhang and Yue‐Xin Ning and Wei Yang and Tian‐Ce Xu and Mei‐Chen Liu and Ke‐Xin Wang and Hui‐Sheng Chen},
  title = {{Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function}},
  booktitle = {Aging},
  year = {2026},
  doi = {10.1111/acel.70400},
}
Figure